Thryv Therapeutics Inc., a clinical-stage biotechnology company advancing a series of novel serum glucocorticoid inducible kinase 1 (SGK1) inhibitors for inherited cardiac arrhythmias, cardiometabolic ...
The government may relax saturated fat limits—but top researchers say the cardiovascular science is still clear. Here’s what that means for your daily diet.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback